Watch Ticker

Supernus Pharmaceuticals, Inc.

Go to Supernus Pharmaceuticals, Inc. Website

$37.05

0.00 (0.00%)

Live

Previous Close

$37.05

Day Range

$0 - $0

Previous Day Range

$35.51 - $37.1

Market Cap

$2.0 billion USD

Day Vol.

Previous Day Vol.

747349

Currency

USD

Primary Exchange

Nasdaq

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

Supernus Pharmaceuticals announced the expiration of the HSR Act waiting period for its proposed acquisition of Sage Therapeutics, with the tender offer continuing and set to expire on July 30, 2025.

Related tickers: SUPN, SAGE.

Read Full Article

N/A - Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

Supernus Pharmaceuticals, a biopharmaceutical company focused on central nervous system diseases, will host a conference call on February 25, 2025, to discuss its fourth quarter and full-year 2024 financial results.

Related tickers: SUPN.

Read Full Article

Trending Tickers

Please sign in to view